Home > Boards > Canadian > Medical - Healthcare >

Covalon Technology Limited (TSXV:COV)

TSXV:COV RSS Feed
Add TSXV:COV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/28/2019 12:03:01 PM - Followers: 24 - Board type: Free - Posts Today: 0

  

Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies that help save lives around the world. Covalon's patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon's technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility.

http://www.covalon.com/
 

Trailing Financial Performance
Fiscal Quarter Products (Wound Care Sales) Medical Coating Systems (Specialized Medical 
Device Coatings)
Development & Consulting Svcs. Licensing & Royalty Fees    Total Revenue Earnings
             
Q2 2019 $12,109,546 - $821,018 $382,069 $13,312,543 ($1,053,908)
Q1 2019 $6,355,538 $830,897 $75,051 $7,261,486 ($907,545)
Q4 2018 $5,862,276 $760,326 $35,084 $6,657,686 $579,183
Q3 2018 $3,074,374 $295,089 $4,546,213 $7,933,676 $2,462,668
Q2 2018 $5,079,373 - $326,664 $321,238 $5,727,275 ($479,082)
Q1 2018 $5,974,640 - $400,289 $29,776 $6,404,705 $568,800
Q4 2017 $9,542,692 - $238,479 $55,782 $9,836,953 $259,160
Q3 2017 $4,031,523 $12,104 $498,951 $1,359,044 $5,901,622 $541,280
Q2 2017 $5,625,575 - $109,147 $270,614 $6,005,336 $473,524
Q1 2017 $5,525,149 - $7,338 $77,440 $5,608,927 $543,110
Q4 2016 $766,852 $4,101 $41,829 $60,293 $872,625 ($2,140,149)
Q3 2016 $2,549,328 $7,576 - $43,098 $2,600,002 ($156,792)
Q2 2016 $469,600 $10,826 $43,299 $274,023 $797,748 ($1,065,517)
Q1 2016 $1,943,231 - $72,000 $425,402 $2,440,633 $267,310
Q4 2015* $1,721,923 $262,500 $40,800 $72,198 $2,097,421 ($847,033)
Q3 2015 $1,741,133 $164,215 - $68,989 $1,974,337 ($129,272)
Q2 2015 $1,742,672 $312,519 - $125,085 $2,180,276 $264,340
Q1 2015 $767,091 $454,607 - $114,987 $1,336,685 ($229,820)
Q4 2014 $1,099,855 - - $106,304 $1,206,159 ($909,705)
Q3 2014 $1,119,559 $14,100 - $157,719 $1,291,378 ($240,156)
Q2 2014 $1,400,065 $462,000 - $179,526 $2,041,591 $431,211
Q1 2014 $733,590 - - $3,788,611 $4,522,201 $3,120,419
Q4 2013 $1,352,855 $71,092 - $130,706 $1,543,019 $125,319
Q3 2013 $1,411,220 - - $66,412 $1,477,632 $234,826
Q2 2013 $478,371 - - $51,482 $535,224 ($558,831)
Q1/2013 $520,523 - - $51,482 $572,005 ($794,481)
* - The company recategorized their revenues during their 2015 Annual Report review, old category names are written in parentheses in the column headings.  Changes include the addition of a new "Services" category of revenues.  Also, the new "Medical Device Coating Systems" category now longer includes the sales of the company's "SilverCoat Foley Catheter", which are now included in the "Products" category.

 

 


Licensed Products 

Smith&Nephew, BIOSTEP Collagen Matrix Dressing:
BIOSTEP webpage:  http://www.smith-nephew.com/professional/products/advanced-wound-management/biostep/

Medline, Silvertouch 100% Silicone Foley Catheters:
Silvertouch Foley Catheters webpage:  http://www.medline.com/product/Silvertouch-100-Silicone-Foley-Catheters/Z05-PF02119

 


 

Products marketed by Covalon

Advanced Wound Care Products:  https://www.covalon.com/advanced-wound-care-products

Vascular Access Products:  https://www.covalon.com/ivclear-antimicrobial-clear-silicone-adhesive-iv-dressing

Moisture Barriers:  https://www.covalon.com/moisture-barriers

Perioperative Care:  https://www.covalon.com/surgiclear-antimicrobial-clear-silicone-adhesive-surgical-dressing

Urology:  https://www.covalon.com/urology

 
 

 

TSXV:COV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#424   CC was the worst I've heard from them. TheMonolith 08/28/19 12:03:01 PM
#423   Hitting 1.20 today. Looking pretty ugly. No timing Traderfan 08/28/19 10:37:35 AM
#422   Brian said "more" and hinted at some big TheMonolith 08/01/19 04:56:43 PM
#421   Right, another unknown. I'm hoping it is TheMonolith 08/01/19 04:55:07 PM
#420   Yes I got a few today but I'm Traderfan 08/01/19 04:44:32 PM
#419   Unfortunate financing for those of us who hold zenvesting 08/01/19 04:23:30 PM
#418   You never said if you bought, just that TheMonolith 08/01/19 04:13:19 PM
#417   As I just said on stockhouse, yes I Traderfan 08/01/19 04:08:03 PM
#416   You taking a chance at these levels? TheMonolith 08/01/19 03:59:03 PM
#415   I had said after the bad update that TheMonolith 08/01/19 03:58:40 PM
#414   Kinda disappointing, and yet.. soo tempting to jump tykundegex 08/01/19 03:39:59 PM
#413   And now a PP at 2.50. Textbook. Traderfan 08/01/19 01:41:51 PM
#412   Unfortunately the blessing of the ME has become TheMonolith 07/25/19 02:31:46 PM
#411   Looks like you can get more even cheaper. Traderfan 07/25/19 09:48:35 AM
#410   Been slowly accumulating all the way down over TheMonolith 07/16/19 04:36:33 PM
#409   All aboard Covalon train again. I paired back TheMonolith 06/06/19 06:11:27 PM
#408   Zack's report - maintains $11 cdn target price stockchase 05/31/19 12:37:19 PM
#407   They're not happy with the bottom line either, zenvesting 05/29/19 12:53:25 PM
#406   The bottom line stinks again this quarter. Revenues Traderfan 05/29/19 10:22:16 AM
#405   Conference Call Scheduled zenvesting 05/28/19 09:41:08 PM
#404   Covalon OEM has two Sales Manager jobs posted, zenvesting 05/28/19 09:07:06 PM
#403   Covalon Announces Second Quarter Fiscal 2019 Results zenvesting 05/28/19 07:51:31 PM
#402   3M to buy Acelity wound care business for zenvesting 05/02/19 08:57:01 AM
#401   Anyone catch the conference call? dr_airtime 03/01/19 02:47:56 AM
#400   Nice board additions, especially today's. Looks like TheMonolith 01/30/19 11:14:24 AM
#399   Wish I'd more than nibbled. Nice to TheMonolith 01/09/19 03:02:35 PM
#398   My first nibble of Covalon since the major TheMonolith 01/08/19 10:16:54 AM
#397   Notes from CC.... dr_airtime 12/20/18 01:16:01 AM
#396   Nice call so far. Yes, really reassuring and zoom22 12/18/18 09:20:31 AM
#395   Like the CEO’s statement. Very reassuring. I’ll post dr_airtime 12/18/18 09:16:55 AM
#394   To Paraphrase what I just heard along the zoom22 12/18/18 09:14:12 AM
#393   This should do it. eom. zenvesting 12/18/18 09:06:26 AM
#392   So I-Hub requires me to make 4 new zenvesting 12/18/18 09:05:58 AM
#391   I want to update the financial tables in zenvesting 12/18/18 09:04:26 AM
#390   Comments in today's earnings PR about the new zenvesting 12/17/18 11:05:30 PM
#389   Agreed TheMonolith 11/28/18 06:12:30 PM
#388   There is one big risk here, the huge Traderfan 11/28/18 05:28:07 PM
#387   COV.V - finally bought back at $C 5.90 today.... dr_airtime 11/26/18 01:11:00 PM
#386   What are your thoughts going forward and with CPTMatt 11/06/18 02:14:30 PM
#385   36 cent close or higher please TheMonolith 09/20/18 03:09:31 PM
#384   AquaGuard acquisition TheMonolith 09/20/18 03:06:42 PM
#383   Covalon is holding support well. A break TheMonolith 09/18/18 10:21:31 AM
#382   Testimonial video https://www.youtube.com/watch?v=T8ZQvEwcaqI&feature=youtu.be TheMonolith 09/12/18 01:50:31 PM
#381   Fellow COV CVLAF investors and those researching the zoom22 09/06/18 11:05:20 PM
#380   Congratulations on your years of DD and it TheMonolith 08/30/18 11:11:40 AM
#379   This is why I have held this stock zenvesting 08/28/18 02:18:26 PM
#378   COVALON ANNOUNCES ANOTHER MILESTONE QUARTERLY PROFIT ON EXCELLENT zenvesting 08/28/18 02:11:14 PM
#377   Covalon mentioned at their 2016 AGM some OEM TheMonolith 08/20/18 10:03:31 AM
#376   I didn't know that. Can you expand on zoom22 08/20/18 09:55:20 AM
#375   BSX has been seen on their investor decks TheMonolith 08/20/18 09:49:04 AM
PostSubject